Former Paradigm Peptides Customer? How to Vet a Research Peptide Supplier Before You Order

The sentencing of Paradigm Peptides owner Matthew Kawa closed the book on a company that sold untested, mislabeled compounds for five years. It also left its customers with a practical problem: how do you choose a supplier you can actually verify, when the last one fabricated everything from its testing claims to its country of origin?

The honest answer is that trust is the wrong tool for this market. Research peptides are not FDA-approved products and are not subject to pre-market review, which means the entire quality system is documentation, and documentation can be checked. What follows is the verification process we believe every researcher should run on any supplier, ours included, before placing an order.

Step 1: What should a peptide COA include?

A certificate of analysis (COA) is the foundational document. But the word "certificate" does a lot of hiding, so be precise about what a real one contains:

A batch or lot number that matches the physical product you receive. A COA without a batch number, or one that never changes across orders, is a brochure.

An HPLC purity result with the actual chromatogram, not just a summary percentage. The chromatogram is what shows whether "99%" reflects a measurement or a copy-paste.

Mass spectrometry identity confirmation. This is the test that catches substitution: the exact failure in the Paradigm case, where products labeled as SARMs contained testosterone. Purity numbers alone cannot catch this: a vial can be 99% pure and 100% the wrong molecule.

The name of the laboratory that performed the analysis. This is the piece most fake COAs omit.

If a supplier cannot produce this document for the specific batch you would receive, stop there. Nothing else on this list matters.

Step 2: How do you verify a COA is real?

A document is only as good as your ability to confirm it. Independent third-party labs will generally verify that they issued a given report number. Look up the named laboratory independently, not through a link the supplier provides, and confirm it exists, does analytical chemistry for outside clients, and issued the certificate in question.

This one step defeats nearly every documentation fraud in the industry. Fabricated COAs almost always name either no lab, a lab that does not exist, or a lab that never performed the work. Paradigm's customers had no chance to catch testosterone substitution at home, but a verified independent identity test would have caught it before a single vial shipped.

Step 3: Check the FDA warning letter database

The FDA maintains a public, searchable database of warning letters. Paradigm Peptides received warning letters in 2020 and 2022, four years and two years before the indictment, and continued operating. Any customer who searched the database would have seen the company's regulatory posture in two minutes.

Make this a standing habit: search the supplier's name and its operating company's name before your first order and periodically after. A warning letter is not always fatal, but an unaddressed one, or a pattern of them, tells you how the company responds to regulators, and Paradigm demonstrated where that road ends.

Step 4: Audit the marketing claims

The claims on a supplier's website are the same claims federal prosecutors examined in the Paradigm case. Read them the way an investigator would:

"FDA-approved." Automatic disqualifier. No research peptide sold in this market is FDA-approved, and a supplier that says otherwise is misrepresenting the single most checkable fact in the industry.

"Made in the USA." Ask for the manufacturing detail behind it. Paradigm used domestic branding on products imported from China and India. A truthful supplier can tell you where synthesis and fill-finish actually happen.

Medical benefit claims aimed at consumers. Research compounds marketed with dosing advice and health promises are being marketed for human use, the exact conduct at the center of the federal charges. A supplier doing this is generating criminal exposure that eventually lands on its customer list, as 54,000 people just learned.

Prices dramatically below the market. Verified synthesis and per-batch third-party testing have a cost floor. Prices far beneath it are usually explained by the absence of one or both.

Step 5: Evaluate operational transparency

Legitimate operations tend to look legitimate in mundane ways: a physical business address that checks out, responsive support that will answer technical questions about testing methodology, consistent batch documentation over time, cold-chain handling where compounds require it, and clear research-use-only positioning without winking consumer marketing.

None of these alone proves anything. Together they form a pattern that is expensive to fake and, more importantly, a pattern that fraudulent operations have historically not bothered to fake, because their customers were not checking.

Supplier verification checklist

Check	Pass looks like	Fail looks like
Certificate of analysis	Batch-specific, with chromatogram and MS identity data	Generic PDF, no batch number, purity claim only
Testing laboratory	Named independent third-party lab, verifiable directly	Unnamed lab, in-house numbers, dead links
FDA warning letters	No letters, or documented resolution	Unaddressed letters, pattern of violations
FDA-approval claims	None; accurate research-use-only positioning	"FDA-approved" anywhere on the site
Origin claims	Named manufacturing detail on request	Flag icons and "USA" branding with no substance
Marketing posture	Educational, research-framed	Dosing guides and consumer health promises

What we changed, and what we already did

Transparency requires saying plainly where we stand. Blackwell BioLabs publishes a certificate of analysis for every batch, including HPLC purity, mass spectrometry identity confirmation, and endotoxin testing, with third-party verification and a ≥99% purity standard. We sell for research use only, and we do not publish dosing guidance or health claims, because no compound we sell is an approved drug.

We are also making a standing commitment prompted by this case: any customer, ours or anyone else's, can contact us with a batch number and we will explain exactly how to verify the corresponding COA with the issuing laboratory. Verification only works as an industry norm if suppliers make it easy.

The Paradigm case did not reveal a new kind of fraud. It revealed how long an old kind can run when nobody checks the paperwork. The 54,000 customers now looking for a supplier have one real defense, and it is the same one that would have protected them before: verify, then order.

For the complete case history, see What happened to Paradigm Peptides, and for the laboratory findings behind the conviction, see Testosterone sold as SARMs: what the case reveals.

Frequently asked questions

What should former Paradigm Peptides customers look for in a new supplier?

Batch-specific certificates of analysis with both HPLC purity and mass-spectrometry identity testing, performed by a named independent laboratory you can verify directly, plus a clean FDA warning-letter history and accurate research-use-only positioning with no FDA-approval claims.

How do I check a peptide supplier's FDA warning letters?

Search the FDA's public warning letter database at fda.gov for the supplier's brand name and legal business name. Paradigm Peptides' 2020 and 2022 letters were publicly visible years before the indictment.

What is the difference between purity testing and identity testing?

HPLC purity testing measures how much of the sample is a single compound; mass spectrometry identity testing confirms which compound it is. Both are required: a sample can be 99% pure and still be entirely the wrong substance, as the Paradigm testosterone findings showed.

Is it legal to buy research peptides?

Research peptides occupy a regulated space: they are not approved drugs and are sold strictly for laboratory research use. Suppliers marketing them for human consumption, with dosing or health claims, are the pattern federal prosecutors charged in the Paradigm case. This is general information, not legal advice.

All products sold by Blackwell BioLabs are for research use only. Nothing in this article is medical advice or a recommendation for human use of any compound discussed.

Sources:

• U.S. Department of Justice, Northern District of Indiana, sentencing press release
• CBS News: "Judge sentences peptide vendor to nearly 6 years in prison for 'an incredible trail of harm'"